What is the dosage of Gilotrif?

Gilotrif is available in 3 dosages, including 20 mg Tab, 30 mg Tab and 40 mg Tab

What does Gilotrif treat?

Gilotrif treats Non-Small-Cell Lung Carcinoma and Squamous Cell Carcinoma

What is Gilotrif made of?

Gilotrif contains afatinib which is a Kinase Inhibitor

How is Gilotrif administered?

Gilotrif is administered as a Oral Pill

What is Gilotrif mechanism of action?

Gilotrif mechanism of action is Protein Kinase Inhibitors

Dosage & Administration Efficacy safety testing Drug label Prior authorization Financial assistance

Patient education

Gilotrif

(afatinib)

afatinib 20 MG Oral Tablet [Gilotrif]afatinib 30 MG Oral Tablet [Gilotrif]

View 1 more

NO BLACK BOX WARNING

Dosage & administration

* Recommended dosage: 40 mg orally once daily
* Renal impairment: 30 mg orally once daily in patients with severe renal impairment
* Instruct patients to take GILOTRIF at least 1 hour before or 2 hours after a meal

eficacy, safety & testing

Gilotrif clinical details

Dosing & Administration

Safety Profile

Real World Evidence

Efficacy: Squamous mNSCLC

Efficacy: mNSCLC with Non-Resistant EGFR Mutations

Efficacy: EGFR M+ mNSCLC with del19

drug label

Gilotrif prescribing information

Have more Gilotrif questions?

Submit MSL Request

Learn More

Need to report a Gilotrif issue?

ONLINE FORMReport adverse event

Learn More

prior authorization

Gilotrif Prior authorization resources

NOT PROVIDED BY BRANDComplete Letter of Medical Necessity

NOT PROVIDED BY BRANDCoverage Authorization Request

NOT PROVIDED BY BRANDCoverage Authorization Appeals

Learn More

Benefits investigation

Gilotrif Presciption & Enrollment Form

Learn More

Reimbursement help (FRM)

NOT PROVIDED BY BRANDReimbursement help (FRM) resources

Learn More

financial assistance

Gilotrif Financial assistance options

Co-pay savings program

commercial only

Enroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Bridge program

commercial only

Learn More

Overview

Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)

Patient benefit

100% free (outside of insurance)

Patient eligibility

HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries

How to sign up

Typically HCP assisted enrollment (via form)

Foundation programs

under insured

no insurance

goverment insurance

65+

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Gilotrif Patient education

Getting started on Gilotrif

NOT PROVIDED BY BRANDInstructions For Use: Squamous mNSCLC

NOT PROVIDED BY BRANDInstructions For Use: mNSCLC with Non-Resistant EGFR Mutations

Patient toolkit

Gilotrif 14-day Tear Sheet

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Gilotrif My Guide

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Track Your Treatment Diary

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Learn More

Gilotrif FAQs

FAQ Data Source

Can't find what you're looking for?

Our trained staff can help you:

Please note:

Access to a Field Reimbursement Manager (FRM) or Medical Science Liaison (MSL) varies by brand and may require talking with your rep first.
Samples are provided at the discretion of the brand.
We are unable to collect Protected Health Information (PHI), fill out forms, or submit them on your behalf.

Gilotrif

Dosage & administration

eficacy, safety & testing

Gilotrif clinical details

drug label

Gilotrif prescribing information

Have more Gilotrif questions?

Need to report a Gilotrif issue?

prior authorization

Gilotrif Prior authorization resources

Benefits investigation

Reimbursement help (FRM)

financial assistance

Gilotrif Financial assistance options

Co-pay savings program

Bridge program

Foundation programs

patient education

Gilotrif Patient education

Getting started on Gilotrif

Patient toolkit

people also ask

Gilotrif FAQs

Can't find what you're looking for?